- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/08 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 277/08
Total number of patents in this class: 17
10-year publication summary
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Promentis Pharmaceuticals, Inc. | 15 |
3 |
| Georgetown University | 628 |
2 |
| LG Chem, Ltd. | 17921 |
1 |
| Janssen Pharmaceutica N.V. | 3171 |
1 |
| Canon Inc. | 43768 |
1 |
| Sumitomo Chemical Company, Limited | 8996 |
1 |
| FerroKin Biosciences, Inc. | 5 |
1 |
| Sunshine Lake Pharma Co., Ltd. | 626 |
1 |
| Universidade Federal de Pernambuco-UFPE | 41 |
1 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3299 |
1 |
| ViiV Healthcare UK (No. 5) Limited | 48 |
1 |
| Whitehead Institute for Biomedical Research | 326 |
1 |
| Tanabe Pharma Corporation | 139 |
1 |
| Universidade Federal do Ceará - UFC | 12 |
1 |
| Other owners | 0 |